Bufotalin-Loaded Biomimetic Prussian Blue Nanoparticles For Colorectal Cancer Chemo-Photothermal Ferroptosis Therapy Article Swipe
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.2217/nnm-2023-0293
· OA: W4390696036
<b>Purpose:</b> We constructed biomimetic nanoparticles with biocompatible, tumor-targeting, laser-responsive properties for ferroptosis-induced colorectal cancer chemo-photothermal therapy, with the aim to realize double-hit ferroptosis treatment for colorectal cancer. <b>Methods:</b> The nanoparticles were prepared by first loading the chemotherapy drug bufotalin (CS-5) with Prussian blue (PB), then combining a hybridized erythrocyte-tumor membrane (M) with PB@CS-5 to produce PB@CS-5@M. The chemo-photothermal therapy efficiency of PB@CS-5@M was tested by <i>in vitro</i> and <i>in vivo</i> experiments. <b>Results and conclusion:</b> The combined PB and CS-5 act as promising ferroptosis inducers to enhance ferroptosis efficacy. The hyperthermia induced by laser stimulation can trigger PB to release CS-5 and iron and ferrous ions, which further promotes ferroptosis.